<?xml version="1.0" encoding="UTF-8"?>
<search_results count="1046">
  <query>SEARCH[STUDY] ( Crohn's Disease [STUDY:ALL-FIELDS] )</query>
  <clinical_study>
    <order>701</order>
    <score>0.5649</score>
    <nct_id>NCT01489943</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01489943</url>
    <title>A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease</condition_summary>
    <intervention_summary>Drug: GSK1605786 500 mg; Drug: Midazolam 3 mg; Drug: Pioglitazone 15 mg; Drug: Omeprazole 40 mg; Drug: Rosuvastatin 10 mg</intervention_summary>
    <last_changed>July 24, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>702</order>
    <score>0.5649</score>
    <nct_id>NCT01114607</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01114607</url>
    <title>A Study to Assess the Relative Bioavailability of Four New Formulations of GSK1605786 in Healthy Subjects</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease</condition_summary>
    <intervention_summary>Drug: GSK1605786 ChemoCentryx: formulation A; Drug: GSK1605786 GSK: formulation B; Drug: GSK1605786 GSK direct-fill: formulation C; Drug: GSK1605786 GSK modified-process: formulation D; Drug: GSK1605786 GSK tablet: formulation E</intervention_summary>
    <last_changed>July 13, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>703</order>
    <score>0.56433</score>
    <nct_id>NCT02088944</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02088944</url>
    <title>a Single-center Registered Clinical Research of Chinese Patients With Moderate to Severe Crohn's Disease</title>
    <status open="N">Unknown status</status>
    <condition_summary>Serological C Reactive Protein or Erythrocyte Sedimentation Rate</condition_summary>
    <intervention_summary>Drug: Infliximab</intervention_summary>
    <last_changed>March 13, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>704</order>
    <score>0.56408</score>
    <nct_id>NCT02481687</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02481687</url>
    <title>The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel Disease</title>
    <status open="N">Unknown status</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis; Dysplasia</condition_summary>
    <intervention_summary>Other: Confocal laser endomicroscopy</intervention_summary>
    <last_changed>June 24, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>705</order>
    <score>0.56325</score>
    <nct_id>NCT01216514</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01216514</url>
    <title>Serologic Markers for Inflammatory Bowel Disease During Clinical Forms With Weak or Strong Evolution Capacities</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <last_changed>November 2, 2011</last_changed>
  </clinical_study>
  <clinical_study>
    <order>706</order>
    <score>0.56302</score>
    <nct_id>NCT02717117</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02717117</url>
    <title>Magnetic Resonance Imaging of Motility in Crohn's 1</title>
    <status open="N">Completed</status>
    <condition_summary>Healthy</condition_summary>
    <intervention_summary>Other: Soup meal</intervention_summary>
    <last_changed>January 4, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>707</order>
    <score>0.56022</score>
    <nct_id>NCT01289366</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01289366</url>
    <title>Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn´s Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Device: Endocytoscopy</intervention_summary>
    <last_changed>August 10, 2011</last_changed>
  </clinical_study>
  <clinical_study>
    <order>708</order>
    <score>0.55871</score>
    <nct_id>NCT00868660</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00868660</url>
    <title>Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Drug: ZP1848</intervention_summary>
    <last_changed>November 1, 2010</last_changed>
  </clinical_study>
  <clinical_study>
    <order>709</order>
    <score>0.55801</score>
    <nct_id>NCT02335281</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02335281</url>
    <title>Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Disease; Ulcerative Colitis; Crohn's Disease</condition_summary>
    <intervention_summary>Procedure: FMT; Drug: Mesalazine</intervention_summary>
    <last_changed>January 8, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>710</order>
    <score>0.55525</score>
    <nct_id>NCT02862132</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02862132</url>
    <title>Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis; Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Drug: Vedolizumab</intervention_summary>
    <last_changed>March 27, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>711</order>
    <score>0.55492</score>
    <nct_id>NCT02423512</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02423512</url>
    <title>The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <last_changed>December 7, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>712</order>
    <score>0.55447</score>
    <nct_id>NCT02502552</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02502552</url>
    <title>Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis; Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Other: blood specimen</intervention_summary>
    <last_changed>October 30, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>713</order>
    <score>0.5539</score>
    <nct_id>NCT02185183</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02185183</url>
    <title>Oral Administration of AlequelTM for Patients With Inflammatory Bowel Disease (IBD)</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease</condition_summary>
    <intervention_summary>Drug: Alequel</intervention_summary>
    <last_changed>September 21, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>714</order>
    <score>0.55241</score>
    <nct_id>NCT00639821</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00639821</url>
    <title>Mucosal Gene Expression Defects in IBD</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <last_changed>October 19, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>715</order>
    <score>0.55188</score>
    <nct_id>NCT02727959</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02727959</url>
    <title>Inflammatory Bowel Disease in South Eastern Norway</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Colitis, Ulcerative; Crohn Disease; Inflammatory Bowel Disease</condition_summary>
    <last_changed>November 15, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>716</order>
    <score>0.54948</score>
    <nct_id>NCT01731665</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01731665</url>
    <title>Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis; Epidemiology; Korea</condition_summary>
    <last_changed>July 11, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>717</order>
    <score>0.54708</score>
    <nct_id>NCT00679003</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00679003</url>
    <title>Managing Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Behavioral: SLCBT; Behavioral: ES</intervention_summary>
    <last_changed>April 14, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>718</order>
    <score>0.54609</score>
    <nct_id>NCT01012726</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01012726</url>
    <title>Study About the Effect of Doxycycline and Acetylcystein in the Treatment of CD-associated Fistulae</title>
    <status open="N">Terminated</status>
    <condition_summary>Crohn's Disease</condition_summary>
    <intervention_summary>Procedure: Colonoscopy</intervention_summary>
    <last_changed>December 3, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>719</order>
    <score>0.53491</score>
    <nct_id>NCT00277251</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00277251</url>
    <title>Alendronate Osteoporosis Study</title>
    <status open="N">Completed</status>
    <condition_summary>Glucocorticoid-Associated Osteopenia and Osteoporosis</condition_summary>
    <intervention_summary>Drug: Alendronate</intervention_summary>
    <last_changed>April 10, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>720</order>
    <score>0.53294</score>
    <nct_id>NCT00610207</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00610207</url>
    <title>Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft</title>
    <status open="N">Terminated</status>
    <condition_summary>Anal Fistula; Crohn's Disease</condition_summary>
    <intervention_summary>Device: Surgisis Biodesign Anal Fistula Plug (SurgiSIS AFP)</intervention_summary>
    <last_changed>December 29, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>721</order>
    <score>0.52507</score>
    <nct_id>NCT02539368</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02539368</url>
    <title>Post-Marketing Use Of Inflectra (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases; Ulcerative Colitis; Crohn's Disease</condition_summary>
    <intervention_summary>Drug: Inflectra (infliximab)</intervention_summary>
    <last_changed>July 14, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>722</order>
    <score>0.52464</score>
    <nct_id>NCT03091309</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03091309</url>
    <title>Counseling to Optimize Adherence in Expectant Mothers With Inflammatory Bowel Disease</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases; Medication Adherence; Crohn Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Other: Interactive educational video; Behavioral: Initial in-person counseling with an IBD nurse; Behavioral: Motivational interviewing; Behavioral: Telemedicine-based follow-up; Other: Monthly follow-up questionnaires; Other: Comprehensive questionnaires</intervention_summary>
    <last_changed>August 1, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>723</order>
    <score>0.52459</score>
    <nct_id>NCT03223012</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03223012</url>
    <title>Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Ankylosing Spondylitis, in the Portuguese National Health Service</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis; Rheumatoid Arthritis; Psoriatic Arthritis; Psoriasis and Ankylosing Spondylitis</condition_summary>
    <last_changed>July 18, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>724</order>
    <score>0.51726</score>
    <nct_id>NCT01496053</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01496053</url>
    <title>Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD)</title>
    <status open="N">Unknown status</status>
    <condition_summary>Ulcerative Colitis; Crohn's Disease; Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Dietary Supplement: AndoSan; Dietary Supplement: Sugar Extract</intervention_summary>
    <last_changed>April 13, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>725</order>
    <score>0.51672</score>
    <nct_id>NCT03218202</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03218202</url>
    <title>Stricture Definition and Treatment (STRIDENT) Observational Study.</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases; Crohn Disease; Ulcerative Colitis; Stricture; Colon</condition_summary>
    <last_changed>July 12, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>726</order>
    <score>0.50914</score>
    <nct_id>NCT01037322</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01037322</url>
    <title>Cannabidiol for Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Drug: cannabidiol; Drug: placebo in drops</intervention_summary>
    <last_changed>April 13, 2013</last_changed>
  </clinical_study>
  <clinical_study>
    <order>727</order>
    <score>0.50797</score>
    <nct_id>NCT01086059</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01086059</url>
    <title>OTIS Autoimmune Diseases in Pregnancy Project</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Crohn's Disease; Rheumatoid Arthritis</condition_summary>
    <last_changed>March 22, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>728</order>
    <score>0.50784</score>
    <nct_id>NCT01346826</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01346826</url>
    <title>Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Drug: Standard 2 hours-infusion; Drug: Accelerated 1 hour-infusion; Drug: Accelerated 30 minutes-infusion</intervention_summary>
    <last_changed>July 11, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>729</order>
    <score>0.50555</score>
    <nct_id>NCT00472992</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00472992</url>
    <title>Pregnancy Exposure Registry for Tysabri®</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease; Prenatal Exposure; Multiple Sclerosis; Pregnancy</condition_summary>
    <last_changed>August 7, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>730</order>
    <score>0.50532</score>
    <nct_id>NCT01040910</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01040910</url>
    <title>Cannabis for Inflammatory Bowel Disease</title>
    <status open="N">Unknown status</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Drug: smoking of cannabis; Drug: smoking cigarettes with placebo</intervention_summary>
    <last_changed>December 15, 2011</last_changed>
  </clinical_study>
  <clinical_study>
    <order>731</order>
    <score>0.50407</score>
    <nct_id>NCT00204165</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00204165</url>
    <title>Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.</title>
    <status open="N">Unknown status</status>
    <condition_summary>Magnetic Resonance Imaging, Intestine Small, Crohn Disease.</condition_summary>
    <intervention_summary>Procedure: MRI of the small bowel</intervention_summary>
    <last_changed>September 7, 2006</last_changed>
  </clinical_study>
  <clinical_study>
    <order>732</order>
    <score>0.50299</score>
    <nct_id>NCT02131168</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02131168</url>
    <title>Epidemiology of IBD in Hong Kong: An Inception Cohort and Follow up Study</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases; Crohn Disease; Ulcerative Colitis</condition_summary>
    <last_changed>April 23, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>733</order>
    <score>0.49945</score>
    <nct_id>NCT01517516</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01517516</url>
    <title>Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest.</title>
    <status open="N">Completed</status>
    <condition_summary>Irritable Bowel Syndrome; Cyclical Vomiting Syndrome; Ulcerative Colitis; Vulvodynia; Crohn's Disease</condition_summary>
    <last_changed>January 12, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>734</order>
    <score>0.49848</score>
    <nct_id>NCT02750800</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02750800</url>
    <title>Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis; Psoriasis; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <last_changed>May 8, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>735</order>
    <score>0.49671</score>
    <nct_id>NCT01765439</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01765439</url>
    <title>The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Crohn Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Dietary Supplement: VSL#3 (Original De Simone formulation)</intervention_summary>
    <last_changed>July 25, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>736</order>
    <score>0.49456</score>
    <nct_id>NCT02707289</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02707289</url>
    <title>Retrospective Collection of PillCam SB Movies</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Inflammatory Bowel Disease, Crohn Disease</condition_summary>
    <last_changed>April 5, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>737</order>
    <score>0.49088</score>
    <nct_id>NCT00274209</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00274209</url>
    <title>Chromoendoscopy for Ulcerative Colitis Surveillance</title>
    <status open="N">Completed</status>
    <condition_summary>Ulcerative Colitis; Crohn's Disease</condition_summary>
    <intervention_summary>Procedure: Chromoendoscopy with magnification</intervention_summary>
    <last_changed>November 21, 2011</last_changed>
  </clinical_study>
  <clinical_study>
    <order>738</order>
    <score>0.48838</score>
    <nct_id>NCT00968721</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00968721</url>
    <title>Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use</title>
    <status open="N">Terminated</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis</condition_summary>
    <last_changed>April 28, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>739</order>
    <score>0.48587</score>
    <nct_id>NCT02742714</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02742714</url>
    <title>PillCam SBC System Functionality in Established and Suspected IBD Patients</title>
    <status open="N">Completed</status>
    <condition_summary>Chronic Inflammatory Small Bowel Disease; Crohn's Disease</condition_summary>
    <intervention_summary>Device: PillCam SBC system</intervention_summary>
    <last_changed>April 5, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>740</order>
    <score>0.48431</score>
    <nct_id>NCT03115749</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03115749</url>
    <title>Intestinal Mesenchymal Stem Stells and Inflammatory Bowel Diseases</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Other: Intestinal biopsies during colonoscopy; Other: Biopsies taken on surgical specimen</intervention_summary>
    <last_changed>April 10, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>741</order>
    <score>0.48357</score>
    <nct_id>NCT00222378</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00222378</url>
    <title>Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis</condition_summary>
    <last_changed>July 28, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>742</order>
    <score>0.4817</score>
    <nct_id>NCT00215020</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00215020</url>
    <title>Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Ulcerative Colitis; Crohn's Disease</condition_summary>
    <last_changed>January 26, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>743</order>
    <score>0.48142</score>
    <nct_id>NCT00261976</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00261976</url>
    <title>A Long-term Safety Study of Infliximab (Remicade)</title>
    <status open="N">Completed</status>
    <condition_summary>Arthritis, Rheumatoid; Crohn Disease; Psoriasis</condition_summary>
    <intervention_summary>Drug: Infliximab (Remicade)</intervention_summary>
    <last_changed>March 15, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>744</order>
    <score>0.47383</score>
    <nct_id>NCT02367326</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02367326</url>
    <title>Identification of Scores Associated With a Favorable Clinical Response With Thiopurines in IBD Patients</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Other: data collection</intervention_summary>
    <last_changed>September 14, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>745</order>
    <score>0.47292</score>
    <nct_id>NCT00979485</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00979485</url>
    <title>Microparticles in Pediatric Inflammatory Disease</title>
    <status open="N">Terminated</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis</condition_summary>
    <last_changed>June 22, 2011</last_changed>
  </clinical_study>
  <clinical_study>
    <order>746</order>
    <score>0.47087</score>
    <nct_id>NCT01705522</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01705522</url>
    <title>Multimodal Approach in IBD Patients</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Ulcerative Colitis; Crohn's Disease; Nonalcoholic Fatty Liver Disease (NAFLD); Vitamin D Deficiency</condition_summary>
    <last_changed>July 25, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>747</order>
    <score>0.46976</score>
    <nct_id>NCT00745329</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00745329</url>
    <title>The Effect of Infliximab on Sperm Quality</title>
    <status open="N">Unknown status</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Other: sperm quality test</intervention_summary>
    <last_changed>September 2, 2008</last_changed>
  </clinical_study>
  <clinical_study>
    <order>748</order>
    <score>0.46969</score>
    <nct_id>NCT01331551</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01331551</url>
    <title>Mesalamine and Reproductive Health Study</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Colitis Ulcerative; Crohn Disease</condition_summary>
    <last_changed>June 17, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>749</order>
    <score>0.46878</score>
    <nct_id>NCT01314079</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01314079</url>
    <title>Follow-up Study of Autologous Cultured Adipose-derived Stem Cells for the Crohn's Fistula</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease; Fistula</condition_summary>
    <last_changed>November 21, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>750</order>
    <score>0.46797</score>
    <nct_id>NCT03059849</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03059849</url>
    <title>Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Crohn Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Drug: Adalimumab</intervention_summary>
    <last_changed>February 16, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>751</order>
    <score>0.46639</score>
    <nct_id>NCT01417728</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01417728</url>
    <title>Endomicroscopy in IBD Patients</title>
    <status open="N">Unknown status</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis</condition_summary>
    <last_changed>November 29, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>752</order>
    <score>0.46617</score>
    <nct_id>NCT02634060</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02634060</url>
    <title>Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Crohn Disease; Colitis, Ulcerative</condition_summary>
    <intervention_summary>Device: Home Based Fecal Calprotectin</intervention_summary>
    <last_changed>August 17, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>753</order>
    <score>0.46511</score>
    <nct_id>NCT03019016</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03019016</url>
    <title>Comparison of Intracorporeal and Extracorporeal Anastomoses for Minimally Invasive Right Colectomy</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Colonic Neoplasms; Crohn Disease</condition_summary>
    <intervention_summary>Procedure: Right Colectomy</intervention_summary>
    <last_changed>January 10, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>754</order>
    <score>0.46494</score>
    <nct_id>NCT02550158</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02550158</url>
    <title>A Study Evaluating the Impact of an Educational Program (EDU-MICI) on Patients With Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Procedure: Educational program EDU-MICI</intervention_summary>
    <last_changed>September 14, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>755</order>
    <score>0.46209</score>
    <nct_id>NCT00290524</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00290524</url>
    <title>Early Alimentation Following Colorectal Surgery</title>
    <status open="N">Unknown status</status>
    <condition_summary>Colorectal Neoplasms; Crohn Disease</condition_summary>
    <intervention_summary>Behavioral: Oral alimentation started 12 hours after colorectal surgery</intervention_summary>
    <last_changed>April 6, 2006</last_changed>
  </clinical_study>
  <clinical_study>
    <order>756</order>
    <score>0.45974</score>
    <nct_id>NCT03000101</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03000101</url>
    <title>Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel Diseases</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Other: 100% pomegranate juice; Other: placebo beverage</intervention_summary>
    <last_changed>December 19, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>757</order>
    <score>0.45617</score>
    <nct_id>NCT00517296</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00517296</url>
    <title>Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn Disease; Rectal Fistula</condition_summary>
    <intervention_summary>Procedure: EUA with seton placement if necessary; Drug: adalimumab; Procedure: EUS</intervention_summary>
    <last_changed>March 10, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>758</order>
    <score>0.45586</score>
    <nct_id>NCT02413047</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02413047</url>
    <title>Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator</title>
    <status open="N">Unknown status</status>
    <condition_summary>Inflammatory Bowel Disease; Ulcerative Colitis; Crohn's Disease</condition_summary>
    <intervention_summary>Drug: Azathioprine; Drug: 6 mercaptopurine; Drug: Methotrexate</intervention_summary>
    <last_changed>August 24, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>759</order>
    <score>0.45081</score>
    <nct_id>NCT02238665</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02238665</url>
    <title>CLE for Differential Diagnosis of IBD</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Device: Endomicroscopy</intervention_summary>
    <last_changed>September 11, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>760</order>
    <score>0.45016</score>
    <nct_id>NCT00061737</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00061737</url>
    <title>Quality of Life in Pediatric Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis</condition_summary>
    <last_changed>January 12, 2010</last_changed>
  </clinical_study>
  <clinical_study>
    <order>761</order>
    <score>0.44257</score>
    <nct_id>NCT02931799</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02931799</url>
    <title>Prevention of Readmissions at IBD Centres of Excellence</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Colitis, Ulcerative; Crohn Disease; Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Behavioral: Nurse Follow-Up; Other: Electronic Monitoring; Other: Post-Discharge Questionnaire; Other: Post-Discharge Questionnaire; Other: Standard of Care</intervention_summary>
    <last_changed>March 8, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>762</order>
    <score>0.44205</score>
    <nct_id>NCT03140306</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03140306</url>
    <title>CT Using MBIR in Crohn's Disease: Prospective Clinical Evaluation of Diagnostic Efficacy, Safety and Patient Outcome.</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Radiology; Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Diagnostic Test: Patients who have had split dose CT</intervention_summary>
    <last_changed>May 12, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>763</order>
    <score>0.44105</score>
    <nct_id>NCT02904590</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02904590</url>
    <title>A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <last_changed>November 30, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>764</order>
    <score>0.43939</score>
    <nct_id>NCT02308917</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02308917</url>
    <title>Canadian Children Inflammatory Bowel Disease Network (CIDsCANN)</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases; Crohn; Ulcerative Colitis</condition_summary>
    <last_changed>December 2, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>765</order>
    <score>0.43777</score>
    <nct_id>NCT00427804</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00427804</url>
    <title>Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption</title>
    <status open="N">Completed</status>
    <condition_summary>Rheumatoid Arthritis; Crohn's Disease</condition_summary>
    <intervention_summary>Drug: calcitriol</intervention_summary>
    <last_changed>January 30, 2013</last_changed>
  </clinical_study>
  <clinical_study>
    <order>766</order>
    <score>0.43586</score>
    <nct_id>NCT03006198</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03006198</url>
    <title>Tracking Biologics Along the Silk Road</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Colitis, Ulcerative</condition_summary>
    <last_changed>April 20, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>767</order>
    <score>0.43541</score>
    <nct_id>NCT02791854</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02791854</url>
    <title>Improving the Quality of Care for Adults With Inflammatory Bowel Disease</title>
    <status open="N">Enrolling by invitation</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis</condition_summary>
    <last_changed>December 13, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>768</order>
    <score>0.43322</score>
    <nct_id>NCT02057016</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02057016</url>
    <title>Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis</condition_summary>
    <last_changed>February 2, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>769</order>
    <score>0.43094</score>
    <nct_id>NCT00462072</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00462072</url>
    <title>Centocor Microarray Study of Patients</title>
    <status open="N">Completed</status>
    <condition_summary>Rheumatoid Arthritis; Psoriatic Arthritis; Psoriasis; Crohn's Disease</condition_summary>
    <intervention_summary>Drug: Infliximab</intervention_summary>
    <last_changed>April 7, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>770</order>
    <score>0.43092</score>
    <nct_id>NCT01032525</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01032525</url>
    <title>Monroe County Inflammatory Bowel Disease (IBD) Registry</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <last_changed>October 12, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>771</order>
    <score>0.43063</score>
    <nct_id>NCT01735461</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01735461</url>
    <title>Calcium Supplements Strategy for Kidney Stones Prevention in Crohn's Patients</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Kidney Calculi; Crohn's Disease</condition_summary>
    <intervention_summary>Dietary Supplement: Calcium Carbonate</intervention_summary>
    <last_changed>April 6, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>772</order>
    <score>0.42999</score>
    <nct_id>NCT02994836</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02994836</url>
    <title>GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Crohn's Disease; Inflammatory Bowel Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Biological: Anti-TNF: Infliximab (Infusion); Drug: Anti-TNF discontinuation: Physiological saline solution; Biological: Anti-TNF:Adalimumab (Subcutaneus); Drug: Anti-TNF discontinuation: Physiological saline solution</intervention_summary>
    <last_changed>December 13, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>773</order>
    <score>0.42935</score>
    <nct_id>NCT01349504</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01349504</url>
    <title>Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Ulcerative Colitis; Crohn's Disease</condition_summary>
    <last_changed>August 16, 2013</last_changed>
  </clinical_study>
  <clinical_study>
    <order>774</order>
    <score>0.4268</score>
    <nct_id>NCT00321412</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00321412</url>
    <title>Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Intestinal Fistula</condition_summary>
    <intervention_summary>Drug: AST-120</intervention_summary>
    <last_changed>May 27, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>775</order>
    <score>0.42634</score>
    <nct_id>NCT02066272</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02066272</url>
    <title>Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease</title>
    <status open="N">Unknown status</status>
    <condition_summary>Inflammatory Bowel Disease; Ulcerative Colitis; Crohn's Disease; Indeterminate Colitis</condition_summary>
    <last_changed>April 6, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>776</order>
    <score>0.42133</score>
    <nct_id>NCT01971970</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01971970</url>
    <title>Biomarkers of Anti-TNF Treatment in IBD</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Biological: Infliximab; Biological: Adalimumab</intervention_summary>
    <last_changed>September 4, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>777</order>
    <score>0.41551</score>
    <nct_id>NCT01991314</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01991314</url>
    <title>Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate</title>
    <status open="N">Completed</status>
    <condition_summary>Ulcerative Colitis; Crohn's Disease</condition_summary>
    <intervention_summary>Drug: Ferrous sulphate</intervention_summary>
    <last_changed>March 31, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>778</order>
    <score>0.41459</score>
    <nct_id>NCT02735941</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02735941</url>
    <title>Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Ulcerative Colitis; Crohn's Disease; Colon Cancer</condition_summary>
    <last_changed>June 13, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>779</order>
    <score>0.41316</score>
    <nct_id>NCT00988273</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00988273</url>
    <title>Confocal Endomicroscopy During Endoscopy</title>
    <status open="N">Unknown status</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Device: Confocal endomicroscopy; Device: Confocal endomicroscopy</intervention_summary>
    <last_changed>April 27, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>780</order>
    <score>0.4094</score>
    <nct_id>NCT03014219</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03014219</url>
    <title>Phase 1 Crohn's Pediatric Sub-study of MSC AFP</title>
    <status open="N">Withdrawn</status>
    <condition_summary>Perianal Fistula</condition_summary>
    <intervention_summary>Drug: Only 1 arm: treatment with MSC-AFP</intervention_summary>
    <last_changed>July 3, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>781</order>
    <score>0.40917</score>
    <nct_id>NCT00588393</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00588393</url>
    <title>FolateScan in Autoimmune Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Rheumatoid Arthritis; Osteoarthritis; Multiple Sclerosis; Crohn's Disease; Systemic Lupus Erythematosus</condition_summary>
    <intervention_summary>Drug: FolateScan (Technetium Tc 99mEC20)</intervention_summary>
    <last_changed>April 15, 2010</last_changed>
  </clinical_study>
  <clinical_study>
    <order>782</order>
    <score>0.4059</score>
    <nct_id>NCT02392221</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02392221</url>
    <title>Impact of Therapeutic Strategies in the Pediatric Inflammatory Bowel Disease: a Population Based Study (1988-2008).</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Pediatric Inflammatory Bowel Disease</condition_summary>
    <last_changed>January 30, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>783</order>
    <score>0.4031</score>
    <nct_id>NCT01916161</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01916161</url>
    <title>The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis; Anxiety</condition_summary>
    <intervention_summary>Other: Questionnaire</intervention_summary>
    <last_changed>March 21, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>784</order>
    <score>0.40161</score>
    <nct_id>NCT00621257</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00621257</url>
    <title>Vitamin D Levels in Children With IBD</title>
    <status open="N">Terminated</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Dietary Supplement: ergocalciferol; Dietary Supplement: Cholecalciferol</intervention_summary>
    <last_changed>February 18, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>785</order>
    <score>0.4011</score>
    <nct_id>NCT01244386</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01244386</url>
    <title>Low-dose CT Using Iterative Reconstruction in Patients With Inflammatory Bowel Disease</title>
    <status open="N">Unknown status</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <last_changed>November 18, 2010</last_changed>
  </clinical_study>
  <clinical_study>
    <order>786</order>
    <score>0.39869</score>
    <nct_id>NCT00889161</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00889161</url>
    <title>Curcumin in Pediatric Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Ulcerative Colitis; Crohn's Disease</condition_summary>
    <intervention_summary>Drug: Curcumin</intervention_summary>
    <last_changed>June 16, 2010</last_changed>
  </clinical_study>
  <clinical_study>
    <order>787</order>
    <score>0.38994</score>
    <nct_id>NCT02264275</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02264275</url>
    <title>Influence of Aerobic Exercise Training (AET) on Inflammatory Bowel Disease (IBD) in Children and Adolescents</title>
    <status open="N">Unknown status</status>
    <condition_summary>Ulcerative Colitis; Crohn Disease; Depression; Sleep; Quality of Life; Motor Activity</condition_summary>
    <intervention_summary>Behavioral: Aerobic Exercise Training</intervention_summary>
    <last_changed>October 20, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>788</order>
    <score>0.38987</score>
    <nct_id>NCT03173144</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03173144</url>
    <title>Chronic Inflammatory Disease, Lifestyle and Treatment Response</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Autoimmune Diseases; Inflammatory Bowel Diseases; Crohn Disease (CD); Colitis, Ulcerative (UC); Arthritis, Rheumatoid (RA); Spondylarthropathies; Arthritis, Psoriatic (PsA); Psoriasis; Hidradenitis Suppurativa (HS); Uveitis</condition_summary>
    <intervention_summary>Other: Primary exposure variable; Other: Other (exploratory) exposure variables</intervention_summary>
    <last_changed>May 30, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>789</order>
    <score>0.38843</score>
    <nct_id>NCT01908283</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01908283</url>
    <title>Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Diseases; Crohn Disease; Colitis, Ulcerative</condition_summary>
    <intervention_summary>Biological: 13-valent pneumococcal conjugated vaccine (PCV13)</intervention_summary>
    <last_changed>December 29, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>790</order>
    <score>0.3856</score>
    <nct_id>NCT01877577</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01877577</url>
    <title>Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease (CD); Ulcerative Colitis (UC)</condition_summary>
    <intervention_summary>Dietary Supplement: Vitamin D3</intervention_summary>
    <last_changed>July 1, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>791</order>
    <score>0.38433</score>
    <nct_id>NCT01430039</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01430039</url>
    <title>Syndecan-1 a Surrogate Marker for IBD</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Procedure: blood sample; Procedure: Blood sample - venous blood 10 ml.</intervention_summary>
    <last_changed>April 7, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>792</order>
    <score>0.38098</score>
    <nct_id>NCT02680756</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02680756</url>
    <title>Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Anemia, Iron-Deficiency; Inflammatory Bowel Disease; Crohn's Disease</condition_summary>
    <intervention_summary>Drug: Ferric Maltol; Drug: Ferric Carboxy Maltose</intervention_summary>
    <last_changed>July 3, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>793</order>
    <score>0.38023</score>
    <nct_id>NCT01810185</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01810185</url>
    <title>Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease</title>
    <status open="N">Withdrawn</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Drug: Low dose naltrexone; Drug: Placebo</intervention_summary>
    <last_changed>November 19, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>794</order>
    <score>0.38017</score>
    <nct_id>NCT03162432</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03162432</url>
    <title>High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>IBD; Ulcerative Colitis; Crohn Disease</condition_summary>
    <intervention_summary>Drug: Vitamin D3</intervention_summary>
    <last_changed>July 18, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>795</order>
    <score>0.3796</score>
    <nct_id>NCT01083121</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01083121</url>
    <title>Surveillance of Humira Injection in Korean Patients</title>
    <status open="N">Completed</status>
    <condition_summary>Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Crohn's Disease; Psoriasis</condition_summary>
    <last_changed>August 20, 2013</last_changed>
  </clinical_study>
  <clinical_study>
    <order>796</order>
    <score>0.37839</score>
    <nct_id>NCT02343601</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02343601</url>
    <title>Perioperative Hemodynamic Optimization Using the Photoplethysmography in Colorectal Surgery</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Polyp of Large Intestine; Colorectal Neoplasms; Crohn Disease</condition_summary>
    <intervention_summary>Device: Photoplethysmography</intervention_summary>
    <last_changed>December 3, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>797</order>
    <score>0.37791</score>
    <nct_id>NCT02543762</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02543762</url>
    <title>Usefulness of Chromoendoscopy for the Early Detection of Colorectal Cancer Associated With Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Colorectal Cancer</condition_summary>
    <intervention_summary>Procedure: Chromoendoscopy</intervention_summary>
    <last_changed>September 4, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>798</order>
    <score>0.3753</score>
    <nct_id>NCT03131414</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03131414</url>
    <title>The IMAGINE-SPOR CIHR Chronic Disease Network</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>IBS - Irritable Bowel Syndrome; Ulcerative Colitis; Crohn Disease; Healthy</condition_summary>
    <intervention_summary>Other: Diet; Other: Gastrointestinal microbiome</intervention_summary>
    <last_changed>April 24, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>799</order>
    <score>0.37326</score>
    <nct_id>NCT02150551</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02150551</url>
    <title>Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Biological: Allogeneic bone marrow-derived mesenchymal stromal cells</intervention_summary>
    <last_changed>October 19, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>800</order>
    <score>0.37313</score>
    <nct_id>NCT00521950</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00521950</url>
    <title>Cost-effectiveness of TPMT Pharmacogenetics</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Diseases; Crohn Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Genetic: TPMT genotyping; Drug: azathioprine or 6-mercaptopurine; Drug: azathioprine (AZA) or 6-mercaptopurine (6-MP)</intervention_summary>
    <last_changed>March 27, 2014</last_changed>
  </clinical_study>
</search_results>
